Peter Marks

Director of the Center for Biologics Evaluation and Research  • FDA

Peter Marks, M.D., Ph.D. is the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration. The center is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies.

Dr. Marks and center staff are committed to facilitating the development of biological products and providing oversight throughout the product life cycle.

Also Speaking

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy; President, International Society for Cell & Gene Therapy • University of Pennsylvania

Sander Van Deventer

Chief Scientific Officer • Porton Advanced

Alex Klarer

Director of Cell Therapy  • BioCentriq

Event Info


Fun Run